Delivery Order SPE2DB24D8003-SPE2DB25FJUSN
- Not listed
- The federal contract award was made by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business located in Anoka, Minnesota. The $2,266.56 firm fixed-price delivery order is for the supply of ENTRESTO 24 MG-26 MG TABLET 60S, with a completion date of May 22, 2025. Dakota Drug, Inc. holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA as part of the DLA Troop Support Medical's ECAT Generation V Program, which allows...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The $6,816.41 firm fixed-price contract is for the delivery of ENTRESTO 24 MG-26 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of March 17, 2025. Dakota Drug, Inc. is a key supplier for the DLA's Troop Support Medical division, providing a wide range of pharmaceutical and medical products to support U.S. Armed...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The $9,208.44 firm-fixed-price contract is for the delivery of ENTRESTO 49 MG-51 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of February 10, 2025. Dakota Drug, Inc. is a key supplier of pharmaceutical products, medical supplies, and healthcare equipment to the U.S. federal government, with a focus on serving...
- The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed-price delivery order contract valued at $2,096.48 to Dakota Drug, Inc., a self-certified small disadvantaged business. This contract is for the provision of 97 mg-103 mg ENTRESTO tablets, a medication used to treat conditions such as heart failure. The delivery order was placed under Dakota Drug's existing Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, which allows the company to supply a wide range...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical division to Dakota Drug, Inc., a self-certified small disadvantaged business. The $6,354.77 firm fixed-price contract is for the delivery of ENTRESTO 24 MG-26 MG TABLET 60S, a pharmaceutical product, with a completion date of September 19, 2023. Dakota Drug, Inc. is a key supplier for the DLA, holding a $999,999,999.00 Indefinite Delivery Contract (IDC) as part of the DLA Troop Support Medical's...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business located in Anoka, Minnesota. The contract is for the delivery of pharmaceutical products, specifically the medication Entresto 24 mg-26 mg tablets in 60-count bottles. The contract has a total ceiling value of $2,701.93 and a completion date of July 2, 2025. The contract is a firm-fixed price delivery order, and it is not set aside for any...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The $6,070.47 contract is for the supply of ENTRESTO 24 MG-26 MG TABLET 60S, a pharmaceutical product. The contract has a completion date of February 29, 2024. Dakota Drug, Inc. has an extensive history of providing a wide range of pharmaceutical products and medical...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of ENTRESTO 24 MG-26 MG TABLET 60S, a pharmaceutical product. The contract has a ceiling value of $10,729.29 and an ultimate completion date of May 23, 2024. Dakota Drug, Inc. is an established federal contractor, holding a significant single-award Indefinite Delivery Contract (IDC) with the...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $4,706.21, is for the delivery of ENTRESTO 97 MG-103 MG tablets in 60-count packages. The contract is a firm-fixed-price delivery order with a completion date of March 27, 2025. Dakota Drug, Inc. is a key supplier of pharmaceutical products, medical supplies, and healthcare equipment to the U.S. Department of Defense. The...
- This federal contract award, valued at $14,527.64, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of ENTRESTO 49 MG-51 MG TABLET 60S. The contract is a firm-fixed-price delivery order with a period of performance through October 29, 2024. Dakota Drug, Inc. is a key supplier to the DLA, holding a significant single-award Indefinite Delivery Contract (IDC) valued at $999,999,999.00 as part of the DLA Troop...
- SPE2DB24D8003Indefinite Delivery Contract
- SPE2DB24D8003-SPE2DB25FJUSNDelivery Order
This is a federal delivery order contract awarded to Dakota Drug, Inc., a self-certified small disadvantaged business located in Anoka, Minnesota. The $6,494.32 firm fixed-price contract was awarded by the Defense Logistics Agency (DLA) on July 1, 2025, with a completion date of July 2, 2025. The contract is for the supply of the pharmaceutical product ENTRESTO 24 MG-26 MG TABLET 60S, which is used for the treatment of cardiovascular conditions. Dakota Drug, Inc. is a key supplier of pharmaceutical and medical products to the U.S. Armed Forces, holding a significant single-award Indefinite Delivery Contract (IDC) with the DLA valued at $999,999,999.00. This IDC, part of the DLA Troop Support Medical's ECAT Generation V Program, allows the company to efficiently deliver a comprehensive range of critical medical items to various defense healthcare facilities. The current delivery order is an unrestricted, non-set-aside contract, indicating Dakota Drug, Inc.'s broad capabilities in the federal medical supply market.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.5k | 7/1/25 |